يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Margaret E. Gilmour"', وقت الاستعلام: 0.80s تنقيح النتائج
  1. 1
    Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study

    المؤلفون: Suzanne L. Elliott, Lin-Fa Wang, Mark G. Scher, Ina Smith, Christopher J. de Bakker, Heidi J Carroll, Stephen M. Mahler, Paul M. Griffin, Martina L. Jones, Michael Gerometta, E.G. Playford, Benjamin S. Hughes, Christopher C. Broder, Kathleen D. Lynch, Reuben Klein, Kym Hoger, Edwin P. Huang, Dimiter S. Dimitrov, Stephen B. Lambert, Trent P. Munro, Karen Hughes, Margaret E. Gilmour, Debra El Saadi, Peter P. Gray

    المصدر: The Lancet Infectious Diseases. 20:445-454

    مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, Placebo, law.invention, 03 medical and health sciences, Immunogenicity, Vaccine, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, Pharmacokinetics, law, Internal medicine, Humans, Medicine, 030212 general & internal medicine, Dosing, Infusions, Intravenous, Adverse effect, Henipavirus, Glycoproteins, business.industry, Australia, Headache, Healthy Volunteers, Clinical trial, 030104 developmental biology, Infectious Diseases, Tolerability, Cohort, Female, Safety, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6e411cf2bf4039d9f60cd4f39dd2b46
    https://doi.org/10.1016/s1473-3099(19)30634-6

    View record from ScienceDirect Find this article in full text from ProQuest Full Text via ClinicalKey
    أضف إلى المفضلة
  2. 2
    Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Human Monoclonal Antibody Targeting the G Glycoprotein of Henipaviruses in Healthy Adults: A Randomised, First-in-Human Phase 1 Study

    المؤلفون: Peter P. Gray, Karen Hughes, Martina L. Jones, Michael Gerometta, Stephen B. Lambert, Christopher C. Broder, Edwin P. Huang, Suzanne L. Elliott, Lin-Fa Wang, Benjamin S. Hughes, Dimiter S. Dimitrov, Stephen M. Mahler, Heidi J Carroll, Kathleen D. Lynch, Trent P. Munro, Mark G. Scher, Ina Smith, Paul M. Griffin, Reuben Klein, Margaret E. Gilmour, Christopher J. de Bakker, Debra El Saadi, E.G. Playford, Kym Hoger

    المصدر: SSRN Electronic Journal.

    مصطلحات موضوعية: Clinical trial, medicine.medical_specialty, Pharmacokinetics, Tolerability, business.industry, Internal medicine, Good clinical practice, Cohort, medicine, Dosing, Placebo, business, Adverse effect

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e1e40f9a16c0257fc824f97bad508782
    https://doi.org/10.2139/ssrn.3457427

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء